title: Cancer immunotherapy: targeting the difference.
authors.affiliation: Viral Hepatitis Laboratory, Singapore Institute for Clinical Sciences, A(∗)STAR, Singapore.
authors.forename: Sarene
authors.initials: S
authors.lastname: Koh
authors.affiliation: Viral Hepatitis Laboratory, Singapore Institute for Clinical Sciences, A(∗)STAR, Singapore; Program Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore; School of Immunity and Infection, College of Medical and Dental Science, University of Birmingham, Edgbaston, Birmingham, UK. Electronic address: antonio@duke-nus.edu.sg.
authors.forename: Antonio
authors.initials: A
authors.lastname: Bertoletti
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics*; D019264:Adoptive Transfer / Q000379:methods*; D001650:Bile Duct Neoplasms / Q000628:therapy*; D001653:Bile Ducts, Intrahepatic; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D018281:Cholangiocarcinoma / Q000628:therapy*; D005260:Female; D006801:Humans; D016246:Lymphocytes, Tumor-Infiltrating / Q000637:transplantation*; D018417:Th1 Cells / Q000637:transplantation*
chemical_list: D048868:Adaptor Proteins, Signal Transducing
keywords: Cancer; Immunotherapy; Tumour infiltrating lymphocytes